Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Charles Truillet, Matthew F.L. Parker, Loc T. Huynh, Junnian Wei, Khaled M. Jami, Yung-Hua Wang, Yuqin S. Shen, Renuka Sriram, David M. Wilson, John Kurhanewicz, Michael J. Evans
Published Apr 17, 2018 · Vol. 9, No. 29 · pp. 20399-20408
Nomi Zalcman, Tamar Canello, Haim Ovadia, Hanna Charbit, Bracha Zelikovitch, Anat Mordechai, Yakov Fellig, Stav Rabani, Tal Shahar, Alexander Lossos, Iris Lavon
Published Apr 13, 2018 · Vol. 9, No. 28 · pp. 19980-19993
Nils Nesheim, Stuart Ellem, Temuujin Dansranjavin, Christina Hagenkötter, Elena Berg, Rupert Schambeck, Hans-Christian Schuppe, Adrian Pilatz, Gail Risbridger, Wolfgang Weidner, Florian Wagenlehner, Undraga Schagdarsurengin
Published Apr 13, 2018 · Vol. 9, No. 28 · pp. 19623-19639
Rositsa G. Koleva-Kolarova, Marcel J.W. Greuter, Talitha L. Feenstra, Karin M. Vermeulen, Erik F.J. de Vries, David Parkin, Erik Buskens, Geertruida H. de Bock
Published Apr 13, 2018 · Vol. 9, No. 28 · pp. 19836-19846